Erratum: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis (Neuro-Oncology Advances DOI: 10.1093/noajnl/vdaa082)

Iyad Alnahhas, Mouaz Alsawas, Appaji Rayi, Joshua D. Palmer, Raju Raval, Shirley Ong, Pierre Giglio, Mohammad Hassan Murad, Vinay Puduvalli

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis (Neuro-Oncology Advances DOI: 10.1093/noajnl/vdaa082)'. Together they form a unique fingerprint.

Medicine & Life Sciences